Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Risk factors for virological failure and subtherapeutic antiretroviral drug concentrations in HIV-positive adults treated in rural northwestern Uganda ; volume:9 ; number:1 ; day:03 ; month:6 ; year:2009 ; pages:1-11 ; date:12.2009
BMC infectious diseases ; 9, Heft 1 (03.6.2009), 1-11, 12.2009
- Urheber
-
Ahoua, Laurence
- Beteiligte Personen und Organisationen
-
Guenther, Gunar
Pinoges, Loretxu
Anguzu, Paul
Chaix, Marie-Laure
Le Tiec, Clotilde
Balkan, Suna
Olson, David
Olaro, Charles
Pujades-Rodríguez, Mar
SpringerLink (Online service)
- DOI
-
10.1186/1471-2334-9-81
- URN
-
urn:nbn:de:1111-2016030254056
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Ahoua, Laurence
- Guenther, Gunar
- Pinoges, Loretxu
- Anguzu, Paul
- Chaix, Marie-Laure
- Le Tiec, Clotilde
- Balkan, Suna
- Olson, David
- Olaro, Charles
- Pujades-Rodríguez, Mar
- SpringerLink (Online service)
Ähnliche Objekte (12)
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Relationship between different types of non-adherence behaviour and virological response in unselected HIV-positive cohort
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Relationship between different types of non-adherence behaviour and virological response in unselected HIV-positive cohort
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada
The virological durability of first-line ART among HIV-positive adult patients in resource limited settings without virological monitoring: a retrospective analysis of DART trial data
O333 Treatment discontinuation and virological failure amongst HIV-positive individuals starting second-line combination antiretroviral therapy (cART)
Factors Associated with Virological Non-suppression among HIV-Positive Patients on Antiretroviral Therapy in Uganda, August 2014–July 2015
Virological failure reduced with HIV-serostatus disclosure, extra baseline weight and rising CD4 cells among HIV-positive adults in Northwestern Uganda
Drug resistance in HIV patients with virological failure or slow virological response to antiretroviral therapy in Ethiopia
Long-term virological outcome in children receiving first-line antiretroviral therapy
Antiretroviral therapy adherence monitoring and its impact on immuno-virological outcome
Accuracy of WHO immunological criteria in identifying virological failure among HIV-infected adults on First line antiretroviral therapy in Mwanza, North-western Tanzania
Immune restoration during HAART: 8-year follow-up in HIV-positive patients with sustained virological suppression
Relationship between different types of non-adherence behaviour and virological response in unselected HIV-positive cohort
Experience with ritonavir/atazanavir in HIV-positive antiretroviral-naïve individuals commencing therapy
Life expectancy of HIV-positive individuals on combination antiretroviral therapy in Canada